Document is current

Article History

Received: 5 May 2026

Accepted: 10 May 2026

First Online: 2 July 2026

Declarations

:

: A.G.: none; C.L.G.: consultant Provepharm (past 24 months, completed); C.M.: grant support from Coloplast and Boston Scientific, consultant to Coloplast, expert witness for Johnson & Johnson, editor for International Urogynecology Journal ; A.R.: none; A.S.: none; A.C.: investigator Medtronic, speaker PriMed; G.W.C.: cofounder and Chief Medical Officer, Amara Therapeutics; M.A.: editorial stipend, Elsevier, NIH funding, CIRM funding; J.B.: consulting for Applied Medical and Momentis Surgical, Advisory Board Suturion and Oasis Diagnostics; S.C.: MCG Health, paid consultant, ABOG, CCDC Committee Member, Elsevier, authorship royalties for Comprehensive Gynecology, 9th Ed; H.B.G.: Boston Scientific consultant, Medtronic consultant; H.Y.K.: none. E.A.B.: none; E.S.: grant funding from NIH, Foundation for Female Health Awareness, FemPulse, and Cook Myosite; M.L.: none; G.B.: grant funding from Boston Scientific, Associate Editor for Neurourology and Urodynamics ; M.A.T.B.: editorial stipend, Springer; D.R.: none; Y.H.T.: none; V.N.: grant support from AbbVie and UroMems, Consultant to AbbVie, Boston Scientific, Bright Uro, EG427, Iota Biosciences, Juro Sciences, Muvon Therapeutics; J.D.: grant support from GE Healthcare; A.E.H.: none; A.H.: none; R.R.: none; L.Q.: UpToDate Royalties, ABOG BOD for URPS; H.V.E.: none; K. Kenton: expert witness Johnson & Johnson, grant funding from Acinixs and NIH, consultant to CMR Surgical; K.W.: none; K. Kang: none; C.F.: consultant to Collamedix, royalties from UptoDate, editor stipend from Elsevier; S.A.: none.